Library

Protocol

AICAR (50 mg Vial)

Complete dosage protocol and reconstitution guide for AICAR (50 mg Vial).

Updated November 25, 2025 Research guide Research information only
Open calculator preset Build protocol outline TNHL options
Educational reference only. TNHL calculates and organizes user-entered values; it does not diagnose, prescribe, recommend doses, or replace guidance from a qualified professional.
MechanismAICAR (5-aminoimidazole-4-carboxamide ribonucleoside) is a research compound that activates AMP-activated protein kinase (AMPK) [1] , earning the nickname “exercise pill” after studies showed sedentary animals given AICAR experienced dramatic endurance improvements [2] . AICAR is prohibited in sports (WADA classifies it as a metabolic modulator) and is not approved for therapeutic use in humans [1] .
Dosing1,000–3,000 mcg once daily (conservative gradual approach).
ReconstitutionAdd 3.0 mL diluent to a 50 mg vial.
StorageLyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) for up to 4 weeks; avoid freeze–thaw cycles.

Calculator preset

Run the vial math before tracking.

At ~16.67 mg/mL, 1 unit ~ 167 mcg ; 1 mg ~ 6 units and 3 mg ~ 18 units on a U-100 syringe.

Calculate this vial

01 · At a glance

Quickstart Highlights

AICAR (5-aminoimidazole-4-carboxamide ribonucleoside) is a research compound that activates AMP-activated protein kinase (AMPK) [1] , earning the nickname “exercise pill” after studies showed sedentary animals given AICAR experienced dramatic endurance improvements [2] . AICAR is prohibited in sports (WADA classifies it as a metabolic modulator) and is not approved for therapeutic use in humans [1] . This educational protocol presents a once-daily subcutaneous approach for research purposes only.

ReconstituteAdd 3.0 mL bacteriostatic water → ~ 16.7 mg/mL concentration. Research dosing range: 1,000–3,000 mcg once daily (conservative gradual approach).
Reference dose1,000–3,000 mcg once daily (conservative gradual approach).
Easy measuringAt ~16.67 mg/mL, 1 unit ~ 167 mcg ; 1 mg ~ 6 units and 3 mg ~ 18 units on a U-100 syringe.
StorageLyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) for up to 4 weeks; avoid freeze–thaw cycles.
Start with sterile preparation, storage, and injection-site basics before using any calculator output. TNHL is a tracking and education tool only.

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

Standard / Gradual Approach (3 mL = ~16.7 mg/mL)

Phase / setup Dose & frequency Volume / units
Weeks 1–21,000 mcg (1 mg)6 units (0.06 mL)
Weeks 3–42,000 mcg (2 mg)12 units (0.12 mL)
Weeks 5–83,000 mcg (3 mg)18 units (0.18 mL)

1,000–3,000 mcg once daily (conservative gradual approach).

Advanced / Aggressive Approach

Phase / setup Dose & frequency Volume / units
Weeks 1–22,000 mcg (2 mg)12 units (0.12 mL)
Weeks 3–63,000 mcg (3 mg)18 units (0.18 mL)
Weeks 7–125,000 mcg (5 mg)30 units (0.30 mL)

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall; avoid foaming.
  3. Gently swirl/roll until dissolved (do not shake).
  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Peptide Vials 8 weeks (gradual 1–3 mg/day) ≈ 3 vials
  • 12 weeks (2–5 mg/day advanced) ≈ 8 vials
Insulin Syringes Per week: 7 syringes (1/day)
  • 8 weeks: 56 syringes
  • 12 weeks: 84 syringes
Bacteriostatic Water Use 3.0 mL per vial for reconstitution.
  • 8 weeks (3 vials): 9 mL → 1 × 10 mL bottle
  • 12 weeks (8 vials): 24 mL → 3 × 10 mL bottles
Alcohol Swabs One for the vial stopper + one for the injection site each day.
  • Per week: 14 swabs (2/day)
  • 8 weeks: 112 swabs → recommend 2 × 100-count boxes
  • 12 weeks: 168 swabs → recommend 2 × 100-count boxes

Protocol Overview

  • Goal: Activate AMPK pathways to mimic exercise-like metabolic effects [1] [6] .
  • Schedule: Daily subcutaneous injections for 8–12 weeks (research protocols).
  • Dose Range: 1,000–3,000 mcg daily (conservative); up to 5,000 mcg in advanced protocols.
  • Reconstitution: 3.0 mL per 50 mg vial (~16.7 mg/mL) for precise measurements.
  • Storage: Lyophilized frozen at −20 °C (−4 °F); reconstituted refrigerated 2–8 °C (35.6–46.4 °F) for up to 4 weeks [14] .

Dosing Protocol

  • Suggested gradual titration approach for research.
  • Start: 1,000 mcg daily; increase by 1,000 mcg every 2 weeks as tolerated.
  • Target: 2,000–3,000 mcg daily by Weeks 3–8 (conservative).
  • Advanced: Up to 5,000 mcg daily if supported by protocol design.
  • Frequency: Once per day (subcutaneous); maintain consistent AMPK activation [3] .
  • Timing: Any consistent time; rotate injection sites daily.

Storage Instructions

  • Lyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) for up to 4 weeks; avoid freeze–thaw cycles.
  • Storage: Lyophilized frozen at −20 °C (−4 °F); reconstituted refrigerated 2–8 °C (35.6–46.4 °F) for up to 4 weeks [14] .
  • Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.

04 · Good to know

Important Notes

  • This AICAR page is for educational research organization only.
  • Confirm route, dose, contraindications, monitoring, storage, and cycle decisions with qualified professional guidance.
  • Use sterile technique, rotate sites when applicable, and log missed doses, reactions, and inventory changes.

05 · How it works

How This Works

AICAR (5-aminoimidazole-4-carboxamide ribonucleoside) is a research compound that activates AMP-activated protein kinase (AMPK) [1] , earning the nickname “exercise pill” after studies showed sedentary animals given AICAR experienced dramatic endurance improvements [2] .

AICAR is prohibited in sports (WADA classifies it as a metabolic modulator) and is not approved for therapeutic use in humans [1] .

This educational protocol presents a once-daily subcutaneous approach for research purposes only.

The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

06 · Daily habits

Lifestyle Factors

  • Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
  • Track body metrics only if they are relevant to the user's goal and approved data sources.
  • Use consistent timing and logging habits so adherence data is meaningful.

07 · What to expect

Potential Benefits & Side Effects

  • AICAR observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
  • This section is not a claim of therapeutic benefit.

08 · Technique

Injection Technique

Pre-injection preparation
  • Wash hands with soap and water.
  • Wipe the vial stopper and chosen site with alcohol, then let both dry.
  • Confirm the vial concentration, calculator result, and intended draw amount before loading the syringe.
Injection procedure
  • Use the route and needle technique directed by a qualified professional or product instructions.
  • For subcutaneous injections, rotate sites and inject slowly to limit leakage and irritation.
  • Do not reuse needles or syringes.
Post-injection care
  • Dispose of sharps in a puncture-resistant container.
  • Return stored items promptly to the correct temperature.
  • Log dose, site, date, time, inventory change, and any observation.

09 · Evidence

References

TNHL options

Peptide collections stay passive.

Open the TNHL Stan Store option that fits the order size. Product details, checkout, and fulfillment stay off-site.